非手术甲状腺乳头状癌的死亡风险:主动监测的推论
基于SEER数据库1975-2015年T1-4N0M0甲状腺乳头状癌患者,比较非手术与手术治疗的疾病特异性生存(DSS)。共1453例非手术和54718例手术患者,经倾向评分匹配和多变量模型分析发现,年龄和肿瘤大小超过特定阈值后非手术死亡率风险增加;年轻患者(14-55岁)0-4cm癌症10年DSS无差异(99.8% vs 100%,p=0.470)。
要点
- 年轻患者(14-55岁)0-4cm癌症手术与非手术10年DSS无差异(99.8% vs 100%,p=0.470)
- 年龄>75岁且肿瘤>6cm者DSS差异最大(48.1% vs 91.3%,p<0.001)
- 非手术相对风险在年龄>60岁后开始增加,>72岁加速;肿瘤>2.0cm后风险增加,4.5cm后加速
核心结论
- 年龄和肿瘤大小超过特定阈值后,非手术治疗的死亡风险逐渐增加,手术可带来生存获益。
研究设计与样本
- 回顾性队列研究,基于SEER数据库1975-2015年T1-4N0M0甲状腺乳头状癌患者,非手术组1453例,手术组54718例,采用倾向评分匹配和多变量限制性立方样条模型分析。
主要发现
- 年轻患者(14-55岁)0-4cm癌症手术与非手术10年DSS无差异(99.8% vs 100%,p=0.470)。
- 年轻患者4.1-6cm癌症10年DSS无差异(98.8% vs 100%,p=0.599)。
- 年轻患者>6cm癌症10年DSS无差异(97.3% vs 100%,p=0.718)。
- 年龄>75岁且肿瘤>6cm者DSS差异最大(48.1% vs 91.3%,p<0.001)。
- 非手术相对风险在年龄>60岁后开始增加,>72岁加速;肿瘤>2.0cm后风险增加,4.5cm后加速。
关键数值与推荐
- 年轻患者(14-55岁)0-4cm癌症10年DSS非手术99.8% vs 手术100%(p=0.470)。
- 年龄>75岁且肿瘤>6cm者10年DSS非手术48.1% vs 手术91.3%(p<0.001)。
- 非手术相对风险年龄变化点:60岁后开始增加,72岁后加速;肿瘤大小变化点:2.0cm后增加,4.5cm后加速。
临床怎么用
- 对于年轻(14-55岁)且肿瘤≤4cm的甲状腺乳头状癌患者,非手术主动监测可能可行。
- 对于年龄>60岁或肿瘤>2.0cm的患者,应谨慎评估非手术策略,考虑手术获益。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- 非手术组样本量相对较小(1453例)。
- SEER数据库缺乏部分临床细节,如具体监测方案和患者依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Active surveillance is established as an alternative to surgery for papillary thyroid microcarcinomas, but inclusion criteria and mortality risk for pursuing a nonsurgical approach have not been clearly defined. To gauge the feasibility of expanding active surveillance thresholds, we investigated the effects of increasing size and age on disease-specific survival (DSS) in a large nonoperative thyroid cancer cohort, compared against a matched group of surgical patients. Methods: Papillary thyroid carcinoma patients staged T1-4N0M0 were identified in the Surveillance, Epidemiology, and End Results (SEER) database between 1975 and 2015, stratified by nonsurgical and surgical management. Propensity score matching was performed to adjust for imbalances in covariates. Multivariable models were constructed using restricted cubic splines to model nonlinear relationships of age and tumor size with DSS. Results: Overall, 1453 nonoperative patients and 54,718 surgical patients met the inclusion criteria. Collectively, increasing age and size after certain thresholds independently led to greater differences in DSS between nonsurgical and surgical patients. For younger ages (14-55 years), surgical approach compared with nonsurgical approach was not associated with any difference in the 10-year DSS among 0-4 cm cancers (99.8% vs. 100%, p = 0.470), 4.1-6 cm cancers (98.8% vs. 100%, p = 0.599), or >6 cm cancers (97.3% vs. 100%, p = 0.718). Older patients with larger tumors (>75 years, >6 cm) demonstrated the greatest difference in DSS (48.1% vs. 91.3%, p < 0.001). Similar results were found when applying propensity score matching. For age, restricted cubic spline plots showed minimal relative survival hazard in nonoperative cases beginning after age 60 years, with a change point illustrating acceleration in relative hazard beyond age 72 years. For size, relative survival hazard was observed after 2.0 cm and increased slowly with nodule growth up to an inflection point of 4.5 cm. Beyond this, mortality risk escalated with each additional year without plateau. Conclusions: Increasing age and size lead to progressively greater mortality risk without surgery, but only beyond certain thresholds. We define escalating gradients at which a nonsurgical approach may be deemed appropriate, and beyond which survival benefits from surgery become apparent. Such findings reconcile controversial observations regarding age and size in active surveillance and further reshape evolving treatment paradigms in thyroid cancer.
引用
- Ho AS, Luu M, Zalt C, et al. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance. Thyroid. 2019. PMID: 31407637. doi:10.1089/thy.2019.0060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。